Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Interest Coverage Ratio (2021 - 2025)

Oncology Institute's Interest Coverage Ratio history spans 5 years, with the latest figure at 3.6 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 64.7% year-over-year to 3.6; the TTM value through Dec 2025 reached 3.2, up 60.1%, while the annual FY2025 figure was 3.2, 60.1% up from the prior year.
  • Interest Coverage Ratio reached 3.6 in Q4 2025 per TOI's latest filing, up from 4.19 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 1.78 in Q1 2025 to a low of 300.07 in Q2 2022.
  • Average Interest Coverage Ratio over 5 years is 43.64, with a median of 7.93 recorded in 2023.
  • Peak YoY movement for Interest Coverage Ratio: plummeted 2077.9% in 2022, then skyrocketed 96.96% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 13.78 in 2021, then tumbled by 2077.9% to 300.07 in 2022, then soared by 97.38% to 7.88 in 2023, then decreased by 29.67% to 10.21 in 2024, then skyrocketed by 64.7% to 3.6 in 2025.
  • Per Business Quant, the three most recent readings for TOI's Interest Coverage Ratio are 3.6 (Q4 2025), 4.19 (Q3 2025), and 6.0 (Q2 2025).